Assessing the role of stress signalling via p38 MAP kinase in the premature senescence of Ataxia Telangiectasia and Werner syndrome fibroblasts

Biogerontology

Volumn 10, Issue 3, 2009, Pages 253-266

  Davis, Terence ^a   Kipling, David ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

c Jun; HSP27; Inflammatory disease; JNK; Premature ageing; SB203580; Stress induced premature senescence; Therapeutics

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ARTICLE; ATAXIA TELANGIECTASIA; ATHEROSCLEROSIS; CELL AGING; CELL DIVISION; CELL SURVIVAL; CELLULAR STRESS SIGNAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PREMATURE AGING; PRIORITY JOURNAL; SKIN FIBROBLAST; WERNER SYNDROME;

AGING, PREMATURE; ATAXIA TELANGIECTASIA; CELL AGING; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TIME FACTORS; WERNER SYNDROME;

EID: 67349188139     PISSN: 13895729     EISSN: 15736768     Source Type: Journal    
DOI: 10.1007/s10522-008-9179-x     Document Type: Article

References (68)

1. Bagley MC, Davis T, Dix MC, Widdowson CS, Kipling D (2006) Microwave-assisted synthesis of N-pyrazole ureas and the p38alpha inhibitor BIRB 796 for study into accelerated cell ageing. Org Biomol Chem 4:4158-4164. doi: 10.1039/b611493h
2. Bagley MC, Davis T, Dix MC, Rokicki MJ, Kipling D (2007) Rapid synthesis of VX-745: P38 MAP kinase inhibition in Werner syndrome cells. Bioorg Med Chem Lett 17:5107-5110. doi: 10.1016/j.bmcl.2007.07.016
3. Bagley MC, Davis T, Dix MC, Murziani PG, Rokicki MJ, Kipling D (2008) Microwave-assisted synthesis of 5-aminopyrazol-4-yl ketones and the p38(MAPK) inhibitor RO3201195 for study in Werner syndrome cells. Bioorg Med Chem Lett 18:3745-3748. doi: 10.1016/j.bmcl.2008.05.037
4. Baird DM, Davis T, Rowson J, Jones CJ, Kipling D (2004) Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cells. Hum Mol Genet 13:1515-1524. doi: 10.1093/hmg/ddh159
5. Ball LG, Xiao W (2005) Molecular basis of ataxia telangiectasia and related diseases. Acta Pharmacol Sin 26:897-907. doi: 10.1111/ j.1745-7254.2005.00165.x
6. Barzilai A, Rotman G, Shiloh Y (2002) ATM deficiency and oxidative stress: A new dimension of defective response to DNA damage. DNA Repair (Amst) 1:3-25. doi: 10.1016/S1568-7864(01)00007-6
7. Bird J, Ostler EL, Faragher RG (2003) Can we say that senescent cells cause ageing? Exp Gerontol 38:1319-1326. doi: 10.1016/j.exger.2003.09.011
8. Bolderson E, Scorah J, Helleday T, Smythe C, Meuth M (2004) ATM is required for the cellular response to thymidine induced replication fork stress. Hum Mol Genet 13:2937-2945. doi: 10.1093/hmg/ddh316
9. Chang S (2005) A mouse model of Werner syndrome: What can it tell us about aging and cancer? Int J Biochem Cell Biol 37:991-999. doi: 10.1016/ j.biocel.2004.11.007
10. Cheng WH, Muftic D, Muftuoglu M, Dawut L, Morris C, Helleday T, Shiloh Y, Bohr VA (2008) WRN is required for ATM Activation and the S-Phase checkpoint in response to interstrand crosslink-induced DNA double strand breaks. Mol Biol Cell 19:3923-3933. doi: 10.1091/mbc.E07-07-0698
11. Cox LS, Faragher RGA (2007) From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing. Cell Mol Life Sci 64:2620-2641. doi: 10.1007/s00018-007-7123-x (Review)
12. Crawford TO (1998) Ataxia telangiectasia. Semin Pediatr Neurol 5:287-294. doi: 10.1016/S1071-9091(98)80007-7
13. Cristofalo VJ, Allen RG, Pignolo RJ, Martin BG, Beck JC (1998) Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc Natl Acad Sci USA 95:10614-10619. doi: 10.1073/pnas.95.18.10614
14. Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252. doi: 10.1016/S0092-8674(00)00116-1
15. Davis T, Kipling D (2006) Werner syndrome as an example of inflamm-aging: Possible therapeutic opportunities for a progeroid syndrome? Rejuvenation Res 9:402-407. doi: 10.1089/rej.2006.9.402
16. Davis T, Kipling D (2007) Werner syndrome, telomeres and stress signalling: Implications for future therapies? In: Rudolph KL (ed) Telomeres and telomerase in ageing, disease, and cancer. Springer, Berlin, pp 285-308
17. Davis T, Singhrao SK, Wyllie FS, Haughton MF, Smith PJ, Wiltshire M, Wynford-Thomas D, Jones CJ, Faragher RG, Kipling D (2003) Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms. J Cell Sci 116:1349-1357. doi: 10.1242/jcs.00331
18. Davis T, Baird DM, Haughton MF, Jones CJ, Kipling D (2005) Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J Gerontol A Biol Sci Med Sci 60:1386-1393
19. Davis T, Haughton MF, Jones CJ, Kipling D (2006) Prevention of accelerated ageing in the Werner syndrome. Ann N Y Acad Sci 1067:243-247. doi: 10.1196/annals.1354.031
20. Davis T, Wyllie FS, Rokicki MJ, Bagley MC, Kipling D (2007) The role of cellular senescence in Werner syndrome: Toward therapeutic intervention in human premature aging. Ann N Y Acad Sci 1100:455-469. doi: 10.1196/ annals.1395.051
21. Deng Q, Liao R, Wu BL, Sun P (2004) High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J Biol Chem 279:1050-1059. doi: 10.1074/jbc.M308644200
22. Elmore E, Swift M (1976) Growth of cultured cells from patients with ataxia-telangiectasia. J Cell Physiol 89:429-431. doi: 10.1002/ jcp.1040890308
23. Faragher RG, Kill IR, Hunter JA, Pope FM, Tannock C, Shall S (1993) The gene responsible for Werner syndrome may be a cell division "counting" gene. Proc Natl Acad Sci USA 90:12030-12034. doi: 10.1073/pnas.90.24.12030
24. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, Landry J (1997) Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110(Pt 3):357-368
25. Haq R, Brenton JD, Takahashi M, Finan D, Finkielsztein A, Damaraju S, Rottapel R, Zanke B (2002) Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence. Cancer Res 62:5076-5082
26. Harley CB, Futcher AB, Greider CW (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345:458-460. doi: 10.1038/345458a0
27. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585-621. doi: 10.1016/0014-4827(61)90192-6
28. Herbig U, Jobling WA, Chen BP, Chen DJ, Sedivy JM (2004) Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol Cell 14:501-513. doi: 10.1016/S1097-2765(04)00256-4
29. Hoar DI (1975) Letter: Phenotypic manifestations of ataxia-telangiectasia. Lancet 2:1048. doi: 10.1016/S0140-6736(75)90347-5
30. Hofer AC, Tran RT, Aziz OZ, Wright W, Novelli G, Shay J, Lewis M (2005) Shared phenotypes among segmental progeroid syndromes suggest underlying pathways of aging. J Gerontol A Biol Sci Med Sci 60:10-20
31. Huot J, Houle F, Marceau F, Landry J (1997) Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80:383-392
32. Itahana K, Campisi J, Dimri GP (2004) Mechanisms of cellular senescence in human and mouse cells. Biogerontology 5:1-10. doi: 10.1023/ B:BGEN.0000017682.96395.10
33. Iwasa H, Han J, Ishikawa F (2003) Mitogen-activated protein kinase p38 defines the common senescence-signalling pathway. Genes Cells 8:131-144. doi: 10.1046/j.1365-2443.2003.00620.x
34. Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat Rev Mol Cell Biol 1:179-186. doi: 10.1038/35043058
35. Kim GY, Mercer SE, Ewton DZ, Yan Z, Jin K, Friedman E (2002) The stress-activated protein kinases p38 alpha and JNK1 stabilize p21(Cip1) by phosphorylation. J Biol Chem 277:29792-29802. doi: 10.1074/ jbc.M201299200
36. Kipling D, Davis T, Ostler EL, Faragher RG (2004) What can progeroid syndromes tell us about human aging? Science 305:1426-1431. doi: 10.1126/ science.1102587
37. Kojis TL, Gatti RA, Sparkes RS (1991) The cytogenetics of ataxia telangiectasia. Cancer Genet Cytogenet 56:143-156. doi: 10.1016/ 0165-4608(91)90164-P
38. Kudlow BA, Kennedy BK, Monnat RJ Jr (2007) Werner and Hutchinson-Gilford progeria syndromes: Mechanistic basis of human progeroid diseases. Nat Rev Mol Cell Biol 8:394-404. doi: 10.1038/nrm2161
39. Lavin MF, Shiloh Y (1997) The genetic defect in ataxia-telangiectasia. Annu Rev Immunol 15:177-202. doi: 10.1146/annurev.immunol.15.1.177
40. Liu J, Minemoto Y, Lin A (2004) c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis. Mol Cell Biol 24:10844-10856. doi: 10.1128/MCB.24.24.10844-10856.2004
41. Martin GM, Oshima J, Gray MD, Poot M (1999) What geriatricians should know about the Werner syndrome. J Am Geriatr Soc 47:1136-1144
42. McKinnon PJ, Burgoyne LA (1985) Altered cellular morphology and microfilament array in ataxia-telangiectasia fibroblasts. Eur J Cell Biol 39:161-166
43. Metcalfe JA, Parkhill J, Campbell L, Stacey M, Biggs P, Byrd PJ, Taylor AM (1996) Accelerated telomere shortening in ataxia telangiectasia. Nat Genet 13:350-353. doi: 10.1038/ng0796-350
44. Naka K, Tachibana A, Ikeda K, Motoyama N (2004) Stress-induced premature senescence in hTERT-expressing ataxia telangiectasia fibroblasts. J Biol Chem 279:2030-2037. doi: 10.1074/jbc.M309457200
45. Pandita TK (2002) ATM function and telomere stability. Oncogene 21:611-618. doi: 10.1038/sj.onc.1205060
46. Pandita TK, Pathak S, Geard CR (1995) Chromosome end associations, telomeres and telomerase activity in ataxia telangiectasia cells. Cytogenet Cell Genet 71:86-93. doi: 10.1159/000134069
47. Pichierri P, Franchitto A (2004) Werner syndrome protein, the MRE11 complex and ATR: Menage-a-trois in guarding genome stability during DNA replication? Bioessays 26:306-313. doi: 10.1002/bies.10411
48. Rodriguez-Lopez AM, Jackson DA, Iborra F, Cox LS (2002) Asymmetry of DNA replication fork progression in Werner's syndrome. Aging Cell 1:30-39. doi: 10.1046/j.1474-9728.2002.00002.x
49. Rodriguez-Lopez AM, Whitby MC, Borer CM, Bachler MA, Cox LS (2007) Correction of proliferation and drug sensitivity defects in the progeroid Werner's syndrome by Holliday junction resolution. Rejuvenation Res 10:27-40. doi: 10.1089/rej.2006.0503
50. Rotman G, Shiloh Y (1997) Ataxia-telangiectasia: Is ATM a sensor of oxidative damage and stress? Bioessays 19:911-917. doi: 10.1002/ bies.950191011
51. Rotman G, Shiloh Y (1998) ATM: From gene to function. Hum Mol Genet 7:1555-1563. doi: 10.1093/hmg/7.10.1555
52. Rubin H (2002) The disparity between human cell senescence in vitro and lifelong replication in vivo. Nat Biotechnol 20:675-681. doi: 10.1038/ nbt0702-675
53. Saklatvala J (2004) The p38 MAP kinase pathway as a therapeutic target in inflammatory disease. Curr Opin Pharmacol 4:372-377. doi: 10.1016/ j.coph.2004.03.009
54. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NG, Taylor AM, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753. doi: 10.1126/science.7792600
55. Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, Edland SD, Martin GM (1996) Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum Genet 97:750-754. doi: 10.1007/BF02346184
56. Shay JW, Wright WE (2000) Hayflick, his limit, and cellular ageing. Nat Rev Mol Cell Biol 1:72-76. doi: 10.1038/35036093
57. Shiloh Y (1997) Ataxia-telangiectasia and the Nijmegen breakage syndrome: Related disorders but genes apart. Annu Rev Genet 31:635-662. doi: 10.1146/annurev.genet.31.1.635
58. Shiloh Y (2003) ATM and related protein kinases: Safeguarding genome integrity. Nat Rev Cancer 3:155-168. doi: 10.1038/nrc1011
59. Shiloh Y, Tabor E, Becker Y (1982) Colony-forming ability of ataxia-telangiectasia skin fibroblasts is an indicator of their early senescence and increased demand for growth factors. Exp Cell Res 140:191-199. doi: 10.1016/0014-4827(82)90169-0
60. Tchirkov A, Lansdorp PM (2003) Role of oxidative stress in telomere shortening in cultured fibroblasts from normal individuals and patients with ataxia-telangiectasia. Hum Mol Genet 12:227-232. doi: 10.1093/hmg/ ddg023
61. Tollefsbol TO, Cohen HJ (1984) Werner's syndrome: An underdiagnosed disorder resembling premature aging. Age (Omaha) 7:75-88. doi: 10.1007/ BF02432205
62. Vaziri H, West MD, Allsopp RC, Davison TS, Wu YS, Arrowsmith CH, Poirier GG, Benchimol S (1997) ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 16:6018-6033. doi: 10.1093/emboj/16.19.6018
63. Verdun RE, Karlseder J (2006) The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127:709-720. doi: 10.1016/j.cell.2006.09.034
64. Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S, Sun P (2002) Sequential activation of the MEK-extracellular signal-regulated kinase and MKK3/6-p38 mitogen-activated protein kinase pathways mediates oncogenic ras-induced premature senescence. Mol Cell Biol 22:3389-3403. doi: 10.1128/MCB.22.10.3389-3403.2002
65. Wong KK, Maser RS, Bachoo RM, Menon J, Carrasco DR, Gu Y, Alt FW, DePinho RA (2003) Telomere dysfunction and ATM deficiency compromises organ homeostasis and accelerates ageing. Nature 421:643-648. doi: 10.1038/nature01385
66. Wood LD, Halvorsen TL, Dhar S, Baur JA, Pandita RK, Wright WE, Hande MP, Calaf G, Hei TK, Levine F, Shay JW, Wang JJ, Pandita TK (2001) Characterization of ataxia telangiectasia fibroblasts with extended life-span through telomerase expression. Oncogene 20:278-288. doi: 10.1038/sj.onc.1204072
67. Xia SJ, Shammas MA, Shmookler Reis RJ (1996) Reduced telomere length in ataxia-telangiectasia fibroblasts. Mutat Res 364:1-11
68. Yokote K, Hara K, Mori S, Kadowaki T, Saito Y, Goto M (2004) Dysadipocytokinemia in Werner syndrome and its recovery by treatment with pioglitazone. Diabetes Care 27:2562-2563. doi: 10.2337/ diacare.27.10.2562